Adjuvant à base de saponine

European patent · EP0362279 · Deleted

Register entry

Publication number
EP0362279
Application number
EP88905332
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Maintained in amended form
Filed
May 31, 1988
Published
Apr 11, 1990
Granted
Jan 11, 1995
Deleted
May 30, 2008
Reason
Maximum term reached
IPC classes
C07J 17/00 (2006.01)
C07H 15/24 (2006.01)
C07H 1/06 (2006.01)
A61K 35/78 (2000.01)
Priority
US A 55229 29.05.1987
PCT application
PCT/US1988/001842 31.05.1988
PCT publication
WO1988/009336 01.12.1988
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 30, 2008

    Maximum term reached

    Published in +pat+ No 12 in 2008

  2. Dec 31, 2004

    Transferred

    Owner
    Aquila Biopharmaceuticals, Inc., 175 Crossing Boulevard, Suite 200, Framingham/MA 01702, USA → Antigenics, Inc., 3 Forbes Road, Lexington, MA 02421, USA

    Published in +pat+ No 24 in 2004

  3. Nov 30, 1999

    Change

    Published in PIDTJ No 22 in 1999

  4. Feb 15, 1999

    Transferred

    Owner
    Cambridge Biotech Corporation, 365 Plantation Street, Worcester/MA, USA → Aquila Biopharmaceuticals, Inc., 175 Crossing Boulevard, Suite 200, Framingham/MA 01702, USA

    Published in PIDTJ No 3 in 1999

  5. Feb 28, 1995

    Granted

    Published in PIDTJ No 4 in 1995

Parties

Inventor

Kensil, Charlotte A.

Milford, MA 01757, US

Marciani, Dante J.

Hopkinton, MA 01748, US

Beltz, Gerald A.

Lexinton, MA 02173, US

Hung, Chung-Ho

Milford, MA 01757, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.